{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T08:58:14Z","timestamp":1769331494605,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,24]]},"DOI":"10.7759\/cureus.102213","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:44:31Z","timestamp":1769273071000},"source":"Crossref","is-referenced-by-count":0,"title":["Peripartum Management of Refractory Graves\u2019 Thyrotoxicosis"],"prefix":"10.7759","author":[{"given":"Sonam","family":"Tshering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareeha","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith TJ","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L. Graves' disease. N Engl J Med. 2016, 375:1552-65. 10.1056\/NEJMra1510030","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves\u2019 hyperthyroidism","volume":"7","author":"Kahaly GJ","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH. 2018 European thyroid association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J. 2018, 7:167-86. 10.1159\/000490384","journal-title":"Eur Thyroid J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S429561","article-title":"Carbimazole-resistant Grave\u2019s thyrotoxicosis is a diagnostic and therapeutic dilemma, case report with literature review","volume":"16","author":"Ata F","year":"2023","unstructured":"Ata F, Khan AA, Tahir S, Al Amer Z. Carbimazole-resistant Grave\u2019s thyrotoxicosis is a diagnostic and therapeutic dilemma, case report with literature review. Int Med Case Rep J. 2023, 16:783-90. 10.2147\/IMCRJ.S429561","journal-title":"Int Med Case Rep J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.42.697","article-title":"A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance","volume":"42","author":"Li H","year":"1995","unstructured":"Li H, Okuda J, Akamizu T, Mori T. A hyperthyroid patient with Graves' disease who was strongly resistant to methimazole: investigation on possible mechanisms of the resistance. Endocr J. 1995, 42:697-704. 10.1507\/endocrj.42.697","journal-title":"Endocr J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander EK","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, et al.. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017, 27:315-89. 10.1089\/thy.2016.0457","journal-title":"Thyroid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-23-0247","article-title":"Psychiatric complications in Graves' disease","volume":"13","author":"Holmberg M","year":"2024","unstructured":"Holmberg M, Malmgren H, Berglund PF, Johansson B, Nystr\u00f6m HF. Psychiatric complications in Graves' disease. Eur Thyroid J. 2024, 13:10.1530\/ETJ-23-0247","journal-title":"Eur Thyroid J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-3-328","article-title":"Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance","volume":"102","author":"Cooper DS","year":"1985","unstructured":"Cooper DS. Propylthiouracil levels in hyperthyroid patients unresponsive to large doses. Evidence of poor patient compliance. Ann Intern Med. 1985, 102:328-31. 10.7326\/0003-4819-102-3-328","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/649084","article-title":"Resistant thyrotoxicosis in a patient with Graves disease: a case report","volume":"2011","author":"Saleem T","year":"2011","unstructured":"Saleem T, Sheikh A, Masood Q. Resistant thyrotoxicosis in a patient with Graves disease: a case report. J Thyroid Res. 2011, 2011:649084. 10.4061\/2011\/649084","journal-title":"J Thyroid Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2004.10.002","article-title":"Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease","volume":"27","author":"Bunevicius R","year":"2005","unstructured":"Bunevicius R, Velickiene D, Prange AJ Jr. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Gen Hosp Psychiatry. 2005, 27:133-9. 10.1016\/j.genhosppsych.2004.10.002","journal-title":"Gen Hosp Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard JL","year":"2011","unstructured":"Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, Gellad WF. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011, 26:1175-82. 10.1007\/s11606-011-1704-y","journal-title":"J Gen Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease","volume":"55","author":"Amino N","year":"1982","unstructured":"Amino N, Tanizawa O, Mori H, et al.. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab. 1982, 55:108-12. 10.1210\/jcem-55-1-108","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.675","article-title":"The thyroid immunology of the postpartum period","volume":"9","author":"Davies TF","year":"1999","unstructured":"Davies TF. The thyroid immunology of the postpartum period. Thyroid. 1999, 9:675-84. 10.1089\/thy.1999.9.675","journal-title":"Thyroid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.46","article-title":"Immunity, thyroid function and pregnancy: molecular mechanisms","volume":"6","author":"Weetman AP","year":"2010","unstructured":"Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol. 2010, 6:311-8. 10.1038\/nrendo.2010.46","journal-title":"Nat Rev Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00137","article-title":"Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance","volume":"8","author":"Bucci I","year":"2017","unstructured":"Bucci I, Giuliani C, Napolitano G. Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne). 2017, 8:137. 10.3389\/fendo.2017.00137","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2025.2405","article-title":"High Trab titer at diagnosis predicts persistent positivity and relapse in Graves\u2019 disease after prolonged antithyroid therapy","volume":"40","author":"Chen Z","year":"2025","unstructured":"Chen Z, Xu J, Kang W, Zhang Y, Chen R, Gong X. High Trab titer at diagnosis predicts persistent positivity and relapse in Graves\u2019 disease after prolonged antithyroid therapy. Endocrinol Metab (Seoul). 2025, 40:950-60. 10.3803\/EnM.2025.2405","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13327","article-title":"Measuring TSH receptor antibody to influence treatment choices in Graves' disease","volume":"86","author":"Hesarghatta Shyamasunder A","year":"2017","unstructured":"Hesarghatta Shyamasunder A, Abraham P. Measuring TSH receptor antibody to influence treatment choices in Graves' disease. Clin Endocrinol (Oxf). 2017, 86:652-7. 10.1111\/cen.13327","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara A","year":"2012","unstructured":"Yoshihara A, Noh J, Yamaguchi T, et al.. Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012, 97:2396-403. 10.1210\/jc.2011-2860","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen SL","year":"2013","unstructured":"Andersen SL, Olsen J, Wu CS, Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013, 98:4373-81. 10.1210\/jc.2013-2831","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2021.03.068","article-title":"Predictive factors of radioiodine therapy failure in Graves' disease: a meta-analysis","volume":"223","author":"Shalaby M","year":"2022","unstructured":"Shalaby M, Hadedeya D, Toraih EA, et al.. Predictive factors of radioiodine therapy failure in Graves' disease: a meta-analysis. Am J Surg. 2022, 223:287-96. 10.1016\/j.amjsurg.2021.03.068","journal-title":"Am J Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458089-peripartum-management-of-refractory-graves-thyrotoxicosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:44:32Z","timestamp":1769273072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458089-peripartum-management-of-refractory-graves-thyrotoxicosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102213","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,24]]}}}